Who owns Exelixis?

Key details on Exelixis (Ticker: EXEL)

Who owns Exelixis?

Is EXEL a good stock to own? Find out who bought Exelixis, who sold Exelixis (EXEL) stock, and who holds a large position in Exelixis.

Fund Name Number of Shares Share Valuation As Of
Capital Research Global Investors^ 22.57M $138.32M Dec. 31, 2013
Meditor 19.07M $27.46M Dec. 31, 2014
T. Rowe Price Associates 18.56M $26.73M Dec. 31, 2014
FMR 17.14M $26.22M Sept. 30, 2014
Wellington Management Company 16.24M $55.06M June 30, 2014
STATE STREET CORPORATION 15.24M $21.95M Dec. 31, 2014
Vanguard 11.04M $15.90M Dec. 31, 2014
BlackRock Fund Advisors 7.25M $10.44M Dec. 31, 2014
BNP PARIBAS ARBITRAGE, SNC 6.84M $616.42M March 31, 2014
BlackRock Institutional Trust Company, N.A. 6.30M $9.08M Dec. 31, 2014
Dr. Jeffrey R. Jay, M.D. 5.10M $7.80M Sept. 30, 2014
GOLDMAN SACHS 4.53M $6.52M Dec. 31, 2014
BVF 4.20M $6.04M Dec. 31, 2014
SUSQUEHANNA INTERNATIONAL 3.34M $5.12M Sept. 30, 2014
OrbiMed Advisors 2.89M $10.22M March 31, 2014
Deutsche Bank Aktiengesellschaft 2.79M $8.93M June 30, 2014
NORTHERN TRUST 2.59M $9.15M March 31, 2014
Balyasny Asset Management 2.41M $3.47M Dec. 31, 2014
Icahn Capital 2.36M $26.64M March 31, 2011
HealthCor Management 2.25M $7.96M March 31, 2014
NEA Management Company 2.21M $3.18M Dec. 31, 2014
Jennison Associates 2.21M $13.52M Dec. 31, 2013